Yuhan Wang

Yuhan Wang

Auto-generated profile, based on publicly available information

Yuhan Wang

Renmin Hospital of Wuhan University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2025 in Nature and Science of Sleep
Verified
Journal Article
Open access
PDF file
YWYuhan Wang
Yuhan Wang
WYWuriliga Yue
Wuriliga Yue
BZBeini Zhou
Beini Zhou
JZJingyi Zhang
Jingyi Zhang
YHYang He
Yang He
KHKe Hu
Ke Hu
Background: The apnea-hypopnea index (AHI) has limitations in assessing nocturnal hypoxemia and excessive daytime sleepiness (EDS) in obstructive sleep apnea (OSA) patients. This study evaluated whether hourly apnea-hypopnea duration (HAD) and mean apnea-hypopnea duration (MAD) could complement or outperform AHI. Methods: This study included 1069 OSA patients, of whom 754 completed the Epworth Sleepiness Scale (ESS). Multivariable regression models evaluated the associations between AHI, MAD, HAD, and nocturnal hypoxemia, and standardized Z scores were used for comparison. The predictive ability of AHI, MAD, and HAD models for EDS was evaluated using goodness-of-fit indices, and receiver operating characteristic (ROC) curve analysis was performed using bootstrapping techniques. Results: Nocturnal hypoxemia was observed in 317 participants (29.65%). Patients with nocturnal hypoxemia had significantly higher AHI (43.19 ± 18.41 vs 21.78 ± 14.73 events/hour, P < 0.001) and longer HAD (16.71 ± 7.48 vs 8.24 ± 5.40 minutes, P < 0.001). After adjusting for age, sex, and BMI, AHI and HAD were still significantly associated with nocturnal hypoxemia (P < 0.05). Standardized Z scores analysis revealed that HAD had the strongest association with nocturnal hypoxemia (HAD: OR = 3.69, 95% CI: 3.06− 4.46, P < 0.0001; AHI: OR = 3.48, 95% CI: 2.90− 4.18, P < 0.0001; MAD: OR = 1.01, 95% CI: 0.88− 1.15, P = 0.9314) and mean SpO2 (HAD: β = − 0.91, 95% CI: − 1.02−− 0.79, P < 0.0001; AHI: β = − 0.85, 95% CI: − 0.97−− 0.74, P < 0.0001; MAD: β = 0.00, 95% CI: − 0.12− 0.12, P = 0.9595), outperforming AHI and MAD. The HAD model showed the best fit for predicting EDS, with an area under the curve of 0.61 at a threshold of 5.63. Conclusion: The HAD better correlates with OSA-related nocturnal hypoxemia and EDS rather than AHI. The duration of respiratory events warrants more investigation in clinical assessment.

1 April 2025 in Nature and Science of Sleep
Verified
Journal Article
Open access
PDF file
BZBeini Zhou
Beini Zhou
YYYan Yao
Yan Yao
YWYuhan Wang
Yuhan Wang
WYWuriliga Yue
Wuriliga Yue
JZJingyi Zhang
Jingyi Zhang
KHKe Hu
Ke Hu
Purpose: Insulin resistance (IR) plays a significant role in the development of obstructive sleep apnea (OSA). The metabolic score for insulin resistance (METS-IR) is a novel method for assessing IR. This study aims to explore the relationship between METS-IR and the risk of OSA. Patients and Methods: This cross-sectional study included a total of 8297 subjects from NHANES (National Health and Nutrition Examination Survey) database, as well as 581 patients who underwent sleep monitoring in Renmin Hospital of Wuhan University. Logistic regression, subgroup analysis, and receiver operating characteristic (ROC) curve analysis were employed for evaluation. Results: In the American population, a significant positive association was found between METS-IR and increased risk of OSA. For each unit increase in METS-IR, the risk of OSA increased by 4.4% (OR= 1.044; 95% CI: 1.037– 1.059; P < 0.001). A similar relationship was observed in the Chinese population. Multivariate Logistic regression model showed that for each unit increase in METS-IR, the prevalence of OSA increased by 6.7% (OR= 1.067; 95% CI: 1.035– 1.103; P < 0.001), and apnea-hypopnea index (AHI) increased by 0.732 (β= 0.732; 95% CI: 0.573– 0.732; P < 0.001). Gender subgroup analysis further showed that the association between METS-IR and OSA was particularly significant in male participants (OR= 1.111; 95% CI: 1.065– 1.163; P < 0.001). In the ROC analysis, the area under the curve (AUC) value of METS-IR for predicting OSA was 0.777, but it is not statistically significantly different from triglyceride glucose (TyG) (AUC = 0.749; P = 0.054), body mass index (BMI) (AUC = 0.769; P = 0.269), and triglyceride glucose-body mass index (TyG-BMI) (AUC = 0.777; P = 0.996). Conclusion: METS-IR is significantly associated with the risk of OSA and may serve as an effective predictive marker for identifying OSA.

30 September 2026 in Sleep Medicine
Verified
Journal Article
Closed access
XSXiu Shi
Xiu Shi
JKJinyan Ke
Jinyan Ke
XWXiaofeng Wu
Xiaofeng Wu
YWYuhan Wang
Yuhan Wang
YWYixuan Wang
Yixuan Wang

11 September 2025 in Sleep Medicine
Verified
Journal Article
Closed access
YWYuhan Wang
Yuhan Wang
BZBeini Zhou
Beini Zhou
WYWuriliga Yue
Wuriliga Yue
JZJingyi Zhang
Jingyi Zhang
YHYang He
Yang He
KHKe Hu
Ke Hu

19 December 2025 in Respiratory Medicine
Verified
Journal Article
Closed access
YWYuhan Wang
Yuhan Wang
HLHailing Liu
Hailing Liu
JZJingyi Zhang
Jingyi Zhang
JXJiali Xiong
Jiali Xiong
KHKe Hu
Ke Hu

17 October 2025 in Journal of Investigative Medicine
Verified
Journal Article
Closed access
YWYuhan Wang
Yuhan Wang
HLHailing Liu
Hailing Liu
JZJingyi Zhang
Jingyi Zhang
MWMengcan Wang
Mengcan Wang
KHKe Hu
Ke Hu
Preserved ratio impaired spirometry (PRISm) may be in the pre-stage of chronic obstructive pulmonary disease. However, little is known about peripheral eosinophils in PRISm. This study ultimately enrolled 7301 community-dwelling participants aged 20–79 years without airflow obstruction. Participants were categorized based on spirometry into two groups: normal spirometry and PRISm. Peripheral eosinophilia is defined by peripheral eosinophil counts ≥300 cells/µL. Multivariable logistic regression model was employed to examine the association between peripheral eosinophil counts and PRISm, as appropriate. Among the community adults finally recruited, 9.43% of participants exhibited PRISm, while 90.57% exhibited normal spirometry. Compared with the normal spirometry population, PRISm participants had a higher prevalence of peripheral eosinophilia in individuals aged 40–79 years (27.41% vs 21.37%, p = 0.01), non-Hispanic Whites (29.22% vs 21.32%, p = 0.01), those with a body mass index of 18.5–<25 kg/m 2 (25.01% vs 16.75%, p = 0.03), never smokers (23.47% vs 18.65%, p = 0.03), individuals without a history of asthma (26.81% vs 20.67%, p <0.001), and those with FeNO levels <50 parts per billion ( p < 0.05). Multivariable regression analysis showed a significant association between participants with eosinophil counts ≥300 cells/µL and PRISm compared to those with counts <150 cells/µL, with an adjusted odds ratio of 1.39 (95% CI: 1.12, 1.72). Peripheral eosinophilia was associated with PRISm in individuals without airflow obstruction. It is necessary to focus on the characteristics of peripheral eosinophils in this population.